Skip to main content
main-content
Erschienen in: International Urogynecology Journal 5/2017

14.03.2017 | Review Article

Deconstructing the genitourinary syndrome of menopause

verfasst von: Pedro Vieira-Baptista, Claudia Marchitelli, Hope K. Haefner, Gilbert Donders, Faustino Pérez-López

Erschienen in: International Urogynecology Journal | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

The concept of genitourinary syndrome of menopause (GSM) was recently introduced and has been gaining widespread use. While some justifications for its introduction are straightforward, others may be questionable. Numerous unspecific symptoms and signs were included in the definition of the syndrome, but the minimum number required for diagnosis was not established. While the GSM definition is designed to facilitate identifying vulvovaginal and urinary estrogen-deprivation-associated symptoms and signs, several concerns have evolved: (1) the syndrome may result in the underdiagnosis of vulvar and urinary pathology; and (2) serious conditions (e.g., high-grade squamous intraepithelial lesions of the vulva or vulvar intraepithelial neoplasia, differentiated type) may be missed while others may not receive appropriate treatment (e.g., lichen sclerosus, overactive bladder). In addition, the transformation of urogenital symptoms and signs into a syndrome may create an iatrogenization of menopause, which, consequently, can lead to demand for (and offer of) a panacea of treatments. This can be detrimental to the care of women who require focused therapy rather than global treatment addressing a variety of genitourinary conditions, not all of which even require any form of intervention. Women’s needs may be better served by having a more precise urogenital diagnosis.
Literatur
3.
Zurück zum Zitat Donders GGG, Van Bulck B, Van de Walle P, Kaiser RR, Pohlig G, Gonser S, et al. Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor®) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study. Gynecol Obstet Investig. 2010;70:264–72. doi: 10.​1159/​000314016. CrossRef Donders GGG, Van Bulck B, Van de Walle P, Kaiser RR, Pohlig G, Gonser S, et al. Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor®) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study. Gynecol Obstet Investig. 2010;70:264–72. doi: 10.​1159/​000314016. CrossRef
5.
Zurück zum Zitat Vieira-Baptista P, Lima-Silva J, Cavaco-Gomes J, Beires J, Martinez-De-Oliveira J. What differentiates symptomatic from asymptomatic women with lichen sclerosus? Gynecol Obstet Investig. 2015;79:263–8. doi: 10.​1159/​000367788. CrossRef Vieira-Baptista P, Lima-Silva J, Cavaco-Gomes J, Beires J, Martinez-De-Oliveira J. What differentiates symptomatic from asymptomatic women with lichen sclerosus? Gynecol Obstet Investig. 2015;79:263–8. doi: 10.​1159/​000367788. CrossRef
12.
Zurück zum Zitat Vieira-Baptista P, Tavares S, Lima-Silva J, Neves AR, Geraldes F, Águas F. Survey on the knowledge and acceptance of the “genitourinary syndrome of menopause” among Portuguese gynaecologists. Acta Obs Ginecol Port (n.d.) Accepted for publication. Vieira-Baptista P, Tavares S, Lima-Silva J, Neves AR, Geraldes F, Águas F. Survey on the knowledge and acceptance of the “genitourinary syndrome of menopause” among Portuguese gynaecologists. Acta Obs Ginecol Port (n.d.) Accepted for publication.
22.
Zurück zum Zitat Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016. doi: 10.​1016/​j.​ajog.​2016.​07.​045. Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016. doi: 10.​1016/​j.​ajog.​2016.​07.​045.
26.
Zurück zum Zitat Buchholz S, Mögele M, Lintermans A, Bellen G, Prasauskas V, Ortmann O, et al. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer. Climacteric. 2015;18:252–9. CrossRefPubMed Buchholz S, Mögele M, Lintermans A, Bellen G, Prasauskas V, Ortmann O, et al. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer. Climacteric. 2015;18:252–9. CrossRefPubMed
27.
Zurück zum Zitat Donders G, Bellen G, Neven P, Grob P, Prasauskas V, Buchholz S. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. Eur J Clin Microbiol Infect Dis. 2015;34:2023–8. doi: 10.​1007/​s10096-015-2447-1. CrossRefPubMedPubMedCentral Donders G, Bellen G, Neven P, Grob P, Prasauskas V, Buchholz S. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. Eur J Clin Microbiol Infect Dis. 2015;34:2023–8. doi: 10.​1007/​s10096-015-2447-1. CrossRefPubMedPubMedCentral
28.
29.
Zurück zum Zitat Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard J-N, et al. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12weeks. J Steroid Biochem Mol Biol. 2016;159:142–53. CrossRefPubMed Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard J-N, et al. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12weeks. J Steroid Biochem Mol Biol. 2016;159:142–53. CrossRefPubMed
Metadaten
Titel
Deconstructing the genitourinary syndrome of menopause
verfasst von
Pedro Vieira-Baptista
Claudia Marchitelli
Hope K. Haefner
Gilbert Donders
Faustino Pérez-López
Publikationsdatum
14.03.2017
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 5/2017
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-017-3295-6

Weitere Artikel der Ausgabe 5/2017

International Urogynecology Journal 5/2017 Zur Ausgabe

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Gynäkologie und bleiben Sie gut informiert – ganz bequem per eMail.